Adults who reached midlife without high blood pressure, diabetes, or a current smoking habit went on to live an average of nearly 13 more years free of dementia than adults carrying all three, according to a study of more than 12,000 people followed for decades.
The research, published in Neurology Open Access on August 5 and led by NYU Langone Health, drew on the Atherosclerosis Risk in Communities study, a community-based cohort that began in 1986 in four US communities. Researchers analyzed 12,409 participants with a mean age of 56, none of whom had dementia at the start, and followed them for a median of 26.3 years.
The framing matters more than the number. This is an association measured across a large population, not a promise to any individual. The authors state plainly that the study was not designed to prove that avoiding these factors caused the observed delay.
The Gap Between Zero and Three Risk Factors
The headline figure comes from a comparison of extremes, measured from age 55.
Participants with none of the three risk factors were expected to live 30.1 dementia free years. Those with all three averaged 17.5. Compared with carrying none, carrying all three was associated with a 2.69-fold higher hazard of dementia.
But the mechanism behind the gap is not only dementia, and this is the part most coverage flattens. Carrying all three risk factors was associated with a 5.61-fold higher hazard of dying without dementia. Competing mortality was so much greater in the high-risk group that, by age 95, cumulative dementia incidence was actually higher among those with no risk factors, at 42 percent, than among those with three, at 23 percent. People with poor vascular health were not escaping dementia. Many were dying first.
During follow-up, 3,008 participants developed dementia and 5,238 died without ever developing it. Among those who did develop dementia, participants with no risk factors lived a mean of 4.1 years with it, against 3.0 years for those with three.
The three factors were defined in ordinary clinical terms. Diabetes was identified by self-report, medication use or an HbA1c of 6.5 percent or higher. Hypertension was defined as systolic pressure of 140 or higher, diastolic of 90 or higher, or use of blood pressure medication. Smoking status was self-reported, with people who were not current smokers as the comparison group. Roughly 57.5 percent of participants had at least one of the three.
The Study Also Found Differences by Sex and Race
Two findings sit alongside the main result and deserve equal weight.
Women lived longer without dementia than men regardless of how many risk factors they carried, averaging 18.1 dementia free years against 16.6 for men among those with all three. And white participants had more dementia free years than Black participants at every level of risk. Among people with all three risk factors, white participants averaged 19.6 years compared with 16.0 for Black participants.
Those gaps are not explained by the three factors the study measured. Participants with a greater vascular burden also had higher body mass index, lower physical activity and lower educational attainment, and were more likely to be Black and to carry an APOE-e4 allele, which points toward differences in circumstance and access rather than a single biological cause. The study documents the disparity. It does not adjudicate its causes.
What the Study Can and Cannot Establish
This is observational research, and the limits are real.
The design cannot prove cause and effect. Risk factors were measured only once, so changes over time were not captured. That means the study cannot tell you whether quitting smoking at 55, or getting blood pressure under control at 60, recovers any portion of those years.
Senior author Josef Coresh, founding director of NYU Langone's Optimal Aging Institute, framed the finding as an argument for prevention rather than treatment alone. "People need to actively avert these factors in midlife," he said, describing it as a strategy for preserving brain health for more than a decade. He also noted that 42 percent of Americans are at risk of developing dementia at some point after age 55.
Self-reported smoking status introduces some misclassification. Because the cohort was recruited in four specific US communities starting in the 1980s, the participants may not represent the broader population.
What the study adds to existing evidence is scale and duration. Prior work established that midlife vascular risk factors raise dementia risk. This analysis translates that into years of life without dementia, which is a more legible measure for a person deciding whether a blood pressure prescription is worth the trouble.
Dementia risk is also broader than three factors. Modifiable contributors identified in other research include high cholesterol, physical inactivity, hearing loss, depression, social isolation, excessive alcohol use, air pollution exposure, head injury and limited education. This study examined three because the cohort measured them consistently across decades.
The Window and the Numbers Worth Knowing
Coverage has described the midlife window variously as ages 45 to 65, 46 to 70 and 48 to 68, reflecting when the cohort was assessed. The analyses were indexed at age 55. The practical point survives the discrepancy: this is the decade or two when many adults stop seeing a clinician regularly and when blood pressure and blood sugar most often go unmeasured.
Coresh's own recommendation is unglamorous. He has advised knowing your blood pressure and A1c by your 40s and aiming to prevent rather than only treat, through physical activity, lower salt intake and weight control. He added that timing matters for diabetes in particular, since diabetes diagnosed before 60 carries substantially more dementia risk than diabetes appearing at 65.
Both hypertension and early type 2 diabetes usually produce no symptoms. They are diagnosed by numbers, not by how you feel. For smoking, cessation support including counseling and FDA-approved medication substantially improves quit rates over willpower alone, and most insurance plans cover it.
Nobody should start, stop or change a medication based on a study summary. Anyone concerned about memory changes in themselves or a relative should raise it with a clinician rather than self-assessing, since many causes of cognitive change are treatable.
What remains unknown is whether improving these factors after midlife shifts the outcome, which the authors identified as a question for future research. MedicalDaily will report follow-up analyses as they are published.
Frequently Asked Questions
What were the three factors? High blood pressure, diabetes, and current smoking, measured in midlife.
How big was the difference? Participants with none of the three were expected to live 30.1 dementia free years from age 55, compared with 17.5 for those with all three.
Does this prove cause and effect? No. It is an observational study showing an association across a population, not a guaranteed individual outcome.
How many people were studied? 12,409 participants, mean age 56, followed for a median of 26.3 years.
Did the high-risk group get more dementia? They developed it earlier, but by age 95 their cumulative dementia incidence was lower, because far more of them died of other causes first.
Why did women and white participants fare better? The study documented those gaps but did not establish causes.
What should I do first? Find out your blood pressure and A1c numbers, since both conditions are usually symptomless.
